- Home
- HYFT vs DXR Comparison
HYFT vs DXR Comparison
Compare HYFT & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYFT | DXR |
|---|---|---|
| Founded | 1983 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.1M | 59.0M |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | HYFT | DXR |
|---|---|---|
| Price | $1.49 | $10.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $4.33 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 323.6K | 39.6K |
| Earning Date | 09-14-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | $12.86 | $44,489.33 |
| Revenue Next Year | $22.94 | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.99 | $8.56 |
| 52 Week High | $3.00 | $14.76 |
Technical Indicators
Market Signals| Indicator | HYFT | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 57.31 | 44.19 |
| Support Level | $1.23 | $10.28 |
| Resistance Level | $1.50 | $10.99 |
| Average True Range (ATR) | 0.10 | 0.66 |
| MACD | 0.02 | -0.12 |
| Stochastic Oscillator | 40.00 | 22.83 |
Price Performance
Historical ComparisonAbout HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.